Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: a phase II study (Q44199266)

30 November 2017

title

Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: a phase II study (English)

1 reference

30 November 2017

1 reference

1 reference

Marta Santisteban

1 reference

30 November 2017

Javier Rodríguez

1 reference

30 November 2017

Emiliano Calvo

1 reference

30 November 2017

J Cortes

1 reference

30 November 2017

J Perez-Calvo

1 reference

30 November 2017

Rafael Martínez-Monge

1 reference

30 November 2017

Antonio Brugarolas

1 reference

30 November 2017

Oscar Fernández-Hidalgo

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Breast Cancer Research and Treatment

30 November 2017

published in

1 reference

30 November 2017

1 reference

30 November 2017

1 reference

30 November 2017

page(s)

47-56

1 reference

The taxoids. Comparative clinical pharmacology and therapeutic potential

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Phase II trial of docetaxel in advanced anthracycline-resistant or anthracenedione-resistant breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Efficacy and safety of docetaxel (Taxotere) in heavily pretreated advanced breast cancer patients: the French compassionate use programme experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Preclinical activity of taxotere (RP 56976, NSC 628503) against freshly explanted clonogenic human tumour cells: comparison with taxol and conventional antineoplastic agents.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Vinorelbine is an active antiproliferative agent in pretreated advanced breast cancer patients: a phase II study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

The importance of dose intensity in chemotherapy of metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Multivariate analysis of prognostic factors in metastatic breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

High-dose chemotherapy of breast cancer: Current status and developmental strategies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Motility and invasive potency of murine T-lymphoma cells: effect of microtubule inhibitors

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Cytoskeletal agents inhibit motility and adherence of human tumor cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

P-glycoprotein mediated resistance to 5'-nor-anhydro-vinblastine (Navelbine)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Taxol binds to polymerized tubulin in vitro

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Docetaxel (Taxotere), a review of preclinical and clinical experience. Part II: Clinical experience.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

A Review of the Antitumour Activity of Vinorelbine in Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Dose-response in the treatment of breast cancer: a critical review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Window of opportunity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Out of the courtroom and into the clinic

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

High-dose therapy with autologous hematopoietic cell support as salvage treatment for patients with breast cancer who have relapsed after previous high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Docetaxel in combination with doxorubicin or vinorelbine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Docetaxel (Taxotere): single agent activity, development of combination treatment and reducing side-effects

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Treatment of advanced breast cancer with vinorelbine and docetaxel with or without human granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1020273502426

7 January 2021

Identifiers

DOI

10.1023/A:1020273502426

1 reference

Dimensions Publication ID

30 November 2017

1036759913

0 references

1 reference